Indonesia, the world's fourth-most populous country, reported its
first virus case earlier this month and officially has just 19
infections compared to 160 in Singapore. Disease experts have
questioned how many cases could be going undiagnosed in Indonesia.
Singapore's new measures announced late Monday came into effect on
March 7, when authorities said two symptomatic Indonesian travelers
arrived in Singapore.
Both had reported coronavirus symptoms in Indonesia before arriving
in Singapore. One had previously sought treatment at a hospital in
Indonesia's capital Jakarta.
Another case involved a Singaporean who had visited her sister in
Indonesia who had pneumonia.
The health ministry did not say whether its new stance on payment
for treatment related to specific cases.
"In view of the rising number of COVID-19 infections globally, and
the expected rise in the number of confirmed cases in Singapore, we
will need to prioritise the resources at our public hospitals," the
health ministry said in a statement.
Foreigners who are short-term visit pass holders who seek treatment
for COVID-19 in Singapore need to pay but testing for the virus
remains free.
Treatment of severe respiratory infections in Singapore public
hospitals typically cost between S$6,000 - S$8,000 ($4,300-5,800),
according to the Ministry of Health's website.
[to top of second column] |
Of 33 imported cases reported by Singapore to date, 24 involve travel to China -
where the virus first surfaced late last year - three to Indonesia and the
others to Italy, Britain, France and Germany.
Singapore has also determined that some of its local cases had travel history to
Indonesia.
Researchers at the Harvard T.H. Chan School of Public Health, in the United
States, said in a study last month Indonesia's lack of confirmed cases at that
time "may suggest the potential for undetected cases", urging authorities there
to strengthen outbreak surveillance and control.
"Are they (Indonesia) lucky or are they missing cases? It’s a little bit hard to
say...but it’s certainly got people asking the question," said Dale Fisher, a
Singapore-based diseases expert who chairs the Global Outbreak Alert and
Response Network coordinated by the World Health Organisation.
(Reporting by Aradhana Aravindan and John Geddie; Editing by Simon
Cameron-Moore)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|